We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$299M
AUM Growth
+$22.6M
Cap. Flow
+$183K
Cap. Flow %
0.06%
Top 10 Hldgs %
80.57%
Holding
74
New
6
Increased
9
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
GRNT icon
Granite Ridge Resources
GRNT
+$14.1M
2
INTA icon
Intapp
INTA
+$5.76M
3
ABNB icon
Airbnb
ABNB
+$5.51M
4
MNDY icon
monday.com
MNDY
+$2.16M
5
PATH icon
UiPath
PATH
+$1.8M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$10.2M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$9.53M
3
SNOW icon
Snowflake
SNOW
+$2.46M
4
GTLB icon
GitLab
GTLB
+$2.18M
5
MQ icon
Marqeta
MQ
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 49.53%
2 Financials 27.09%
3 Energy 7.46%
4 Consumer Discretionary 5.61%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYZ
51
Block Inc
XYZ
$48.4B
$296K 0.1%
4,317
-12,951
-75% -$969K
GH icon
52
Guardant Health
GH
$21.7B
$250K 0.08%
10,660
XPEV icon
53
XPeng
XPEV
$12.3B
$188K 0.06%
16,903
HUMA icon
54
Humacyte
HUMA
$177M
$163K 0.05%
52,693
SLGC
55
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$138K 0.05%
54,255
ALEC icon
56
Alector
ALEC
$172M
$89.1K 0.03%
14,402
TVRD
57
Tvardi Therapeutics
TVRD
$19.1M
$79.2K 0.03%
448
DTIL icon
58
Precision BioSciences
DTIL
$180M
$59.6K 0.02%
2,637
VIRX
59
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$56.9K 0.02%
35,791
IKT icon
60
Inhibikase Therapeutics
IKT
$341M
$54.5K 0.02%
+13,803
New +$57.6K
ACLX
61
DELISTED
Arcellx
ACLX
-16,055
Closed -$497K
AEVA
62
Aeva Technologies
AEVA
$1.19B
-8,817
Closed -$60K
ASAN icon
63
Asana
ASAN
$1.89B
-15,129
Closed -$208K
CMRC
64
Commerce.com Inc Series 1
CMRC
$256M
-27,100
Closed -$237K
CLSD
65
DELISTED
Clearside Biomedical
CLSD
-4,357
Closed -$73K
GTLB icon
66
GitLab
GTLB
$5.73B
-47,891
Closed -$2.18M
LUNG icon
67
Pulmonx
LUNG
$69.7M
-29,150
Closed -$246K
NCNO icon
68
nCino
NCNO
$2.03B
-34,728
Closed -$918K
PCOR icon
69
Procore
PCOR
$8.27B
-13,125
Closed -$619K
RKLB icon
70
Rocket Lab Corp
RKLB
$40B
-151,192
Closed -$570K
TELA icon
71
TELA Bio
TELA
$30.4M
-41,277
Closed -$475K
VCTR icon
72
Victory Capital Holdings
VCTR
$6.14B
-63,509
Closed -$1.7M
MTTR
73
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
-25,461
Closed -$71K
PHAS
74
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-34,208
Closed -$1K

Similar funds

Hamilton Lane Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Hamilton Lane Advisors held 74 positions worth $299M, up 8.2% from $277M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Hamilton Lane Advisors's Q1 2023 filing shows 6 new, 9 increased, 8 reduced and 14 closed positions. Its largest new stake was Intapp: 164,057 shares worth $7.36M. The largest sale was Nu Holdings, an estimated $10.2M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 45% a quarter earlier, followed by Financials and Energy.

  • Hamilton Lane Advisors's largest Q1 2023 buy was Intapp: 164,057 shares worth $7.36M.
  • Hamilton Lane Advisors added most to Granite Ridge Resources in Q1 2023, an estimated $14.1M increase.
  • Hamilton Lane Advisors's biggest Q1 2023 reduction was Nu Holdings, cutting an estimated $10.2M.
  • Hamilton Lane Advisors fully exited GitLab in Q1 2023, selling an estimated $2.18M.
  • Hamilton Lane Advisors's ten largest holdings make up 81% of its $299M portfolio in Q1 2023.
  • Hamilton Lane Advisors opened 6 new positions and closed 14 in Q1 2023.
  • Hamilton Lane Advisors's portfolio value rose 8.2% quarter-over-quarter to $299M.

Based on Hamilton Lane Advisors's 13F filing for Q1 2023, filed 2 May 2023.